Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bioaffinity Technologies Inc (BIAF)

Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,473
  • Shares Outstanding, K 15,585
  • Annual Sales, $ 2,530 K
  • Annual Income, $ -7,940 K
  • EBIT $ -8 M
  • EBITDA $ -7 M
  • 60-Month Beta 2.85
  • Price/Sales 7.26
  • Price/Cash Flow N/A
  • Price/Book 5.08
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.82
  • Most Recent Earnings $-0.16 on 11/14/24
  • Next Earnings Date 11/12/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8305 +19.54%
on 12/16/24
1.3300 -25.35%
on 11/21/24
-0.2772 (-21.83%)
since 11/20/24
3-Month
0.8305 +19.54%
on 12/16/24
2.2592 -56.06%
on 09/25/24
-1.0672 (-51.81%)
since 09/20/24
52-Week
0.8305 +19.54%
on 12/16/24
3.6200 -72.57%
on 03/05/24
-0.5972 (-37.56%)
since 12/20/23

Most Recent Stories

More News
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer

bioAffinity Technologies , Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, today announced that Michael...

BIAF : 0.9928 (-15.86%)
BIAFW : 0.3000 (-25.69%)
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium

bioAffinity Technologies , Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, will present at the Cleveland...

BIAF : 0.9928 (-15.86%)
BIAFW : 0.3000 (-25.69%)
bioAffinity Technologies to Ring Nasdaq Closing Bell Today

bioAffinity Technologies , Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, will ring the Nasdaq Stock...

BIAF : 0.9928 (-15.86%)
NDAQ : 77.70 (+0.41%)
bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported...

BIAF : 0.9928 (-15.86%)
BIAFW : 0.3000 (-25.69%)
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer

bioAffinity Technologies, Inc . (NASDAQ: BIAF; BIAFW) today announced the publication of a paper titled “Porphyrin-modified beads for use as compensation controls in flow cytometry” in the peer-reviewed...

BIAF : 0.9928 (-15.86%)
bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023

bioAffinity Technologies , Inc. (NASDAQ: BIAF; BIAFW) today announced it will report financial results for the three months ended December 31, 2022, on Friday, March 31, 2023, after the market close....

BIAF : 0.9928 (-15.86%)
bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications

bioAffinity Technologies, Inc . (NASDAQ: BIAF; BIAFW) today announced its commercialization team, including the addition of Julie Anne Overton, a veteran of print and broadcast journalism, corporate communications...

BIAF : 0.9928 (-15.86%)
bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research

bioAffinity Technologies, Inc . (NASDAQ: BIAF; BIAFW) today announced publication of “ Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning ” detailing...

BIAF : 0.9928 (-15.86%)
bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments

bioAffinity Technologies, Inc . (NASDAQ: BIAF; BIAFW) announced today that the U.S. Patent and Trademark Office (USPTO) has provided a Notice of Allowance for a patent application titled “ Porphyrin...

BIAF : 0.9928 (-15.86%)
Argus Research Initiates Equity Research Report Coverage on bioAffinity Technologies, Inc. (NasdaqCM: BIAF)

/PRNewswire/ -- Argus Research, an independent investment research firm, has launched Equity Research Report coverage on bioAffinity Technologies, Inc....

BIAF : 0.9928 (-15.86%)

Business Summary

bioAffinity Technologies Inc. is a cancer diagnostics company which develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung and is researching targeted therapies to treat cancer. bioAffinity Technologies Inc. is based in SAN ANTONIO.

See More

Key Turning Points

3rd Resistance Point 1.5025
2nd Resistance Point 1.3963
1st Resistance Point 1.1945
Last Price 0.9928
1st Support Level 0.8865
2nd Support Level 0.7803
3rd Support Level 0.5785

See More

52-Week High 3.6200
Fibonacci 61.8% 2.5544
Fibonacci 50% 2.2253
Fibonacci 38.2% 1.8961
Last Price 0.9928
52-Week Low 0.8305

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar